The SYNPLYNS brand, founded in 2012 (United States), from 61 sister brands and 17479 competing brands. SYNPLYNS is owned by Biogen Idec, listed on the stock exchange of New York SYNPLYNS is part of the Drug Manufacturers activity sector.

SYNPLYNS is a brand of Biogen Idec (BIIB) News

Biogen Idec (SYNPLYNS) share price

Share price
Popularity of SYNPLYNS (Biogen Idec)

Popularity
Sustainability Biogen Idec

Sustainability
Other brands Biogen Idec

Other brands
Competing brands of SYNPLYNS

Rival brands
News

News

News from the brand SYNPLYNS

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Stock exchange: More information on Biogen Idec (SYNPLYNS)

SYNPLYNS is a brand of Biogen Idec (BIIB) News

News from the brand SYNPLYNS

All news Biogen Idec (SYNPLYNS)

All news
Biogen Idec (SYNPLYNS)